Background A 55-year-old male was diagnosed with poorly differentiated thyroid cancer after total thyroidectomy, which was performed because of progressive enlargement of a dominant thyroid nodule. He developed an early cervical recurrence that was treated with modified neck dissection. He subsequently developed biopsy-proven progressive pulmonary metastases.
Investigations Neck and chest CT scans, laboratory tests, CT-guided fine-needle aspiration biopsy, [18F]-2-fluoro-2-deoxy-D-glucose-PET scan, lesional dosimetry using 124I PET scan, diagnostic radioactive iodine (RAI) scanning, whole-body and blood RAI dosimetry, and single-photon-emission CT.
Diagnosis Stage IV poorly differentiated thyroid cancer.
Management Surgical resection of cervical recurrence, RAI therapy.
Subscribe to Journal
Get full journal access for 1 year
only $4.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Burch HB (1995) Evaluation and management of the solid thyroid nodule. Endocrinol Metab Clin North Am 24: 663–710
Garber JR (2006) Thyroid nodules 2006: managing what has been known for over 50 years. Hormones (Athens) 5: 179–186
Frates MC et al. (2005) Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement—thyroid nodule shape and prediction of malignancy. Radiology 237: 794–800
Ogilvie JB et al. (2006) Current status of fine needle aspiration for thyroid nodules. Adv Surg 40: 223–238
Mazzaferri EL et al. (2001) Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 86: 1447–1463
Cooper DS et al. (2006) Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16: 109–142
Patel KN et al. (2006) Poorly differentiated and anaplastic thyroid cancer. Cancer Control 13: 119–128
Rosai J (2004) Poorly differentiated thyroid carcinoma: introduction to the issue, its landmarks, and clinical impact. Endocr Pathol 15: 293–296
Volante M et al. (2004) Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients. Cancer 100: 950–957
Hiltzik D et al. (2006) Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients. Cancer 106: 1286–1295
Robbins RJ et al. (2004) Factors influencing the basal and recombinant human thyrotropin-stimulated serum thyroglobulin in patients with metastatic thyroid carcinoma. J Clin Endocrinol Metab 89: 6010–6016
Lee N et al. (2006) The role of external beam radiotherapy in the treatment of papillary thyroid cancer. Endocr Relat Cancer 13: 971–977
Tuttle M et al. (2004) Challenging cases in thyroid cancer: a multidisciplinary approach. Eur J Nucl Med Mol Imaging 31: 605–612
Lind P et al. (2006) Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer. Semin Nucl Med 36: 194–205
Robbins RJ et al. (2006) Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning. J Clin Endocrinol Metab 91: 498–505
Sgouros G et al. (2004) Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software. J Nucl Med 45: 1366–1372
RM Tuttle has received honaria and research support from Genzyme. The other authors declared they have no competing interests.
About this article
Cite this article
Tuttle, R., Grewal, R. & Larson, S. Radioactive iodine therapy in poorly differentiated thyroid cancer. Nat Rev Clin Oncol 4, 665–668 (2007). https://doi.org/10.1038/ncponc0979